{
    "uniprot_canonical_ac": "A0A0R4IVY2-1",
    "uniprot_id": [
        {
            "id": "A0A0R4IVY2_DANRE",
            "url": "https://www.uniprot.org/uniprot/A0A0R4IVY2_DANRE",
            "type": "external"
        }
    ],
    "mass": 47233.0,
    "length": 436,
    "protein_name": "Insulin-like growth factor 2 mRNA-binding protein 2b; Uncharacterized protein LOC557028; Uncharacterized protein isoform X1",
    "gene_name": "igf2bp2b",
    "organism": "Zebrafish",
    "refseq_name": "uncharacterized protein LOC557028",
    "refseq_ac": [
        {
            "id": "NP_001082843",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001082843",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "igf2bp2b; si:dkey-24b15.4; wu:fb81e12",
    "gene_names_refseq": "igf2bp2b; si:dkey-24b15.4; wu:fb81e12",
    "protein_names_uniprotkb": "Insulin-like growth factor 2 mRNA-binding protein 2b; Uncharacterized protein LOC557028; Uncharacterized protein isoform X1",
    "protein_names_refseq": "uncharacterized protein LOC557028",
    "tax_id": 7955,
    "disease": "acquired metabolic disease (Disease Ontology:DOID:0060158); type 2 diabetes mellitus (Disease Ontology:DOID:9352)",
    "pathway": " (dre:557028)",
    "pathway_count": 1,
    "publication_count": 3,
    "publication_id_list": "18803835;23594743;26325373",
    "function": "##Evidence-Data-START## CDS exon combination :: EU296399.1, EU296400.1 [ECO:0000331] RNAseq introns :: mixed sample support SAMEA3505371, SAMEA3505372 [ECO:0006172] ##Evidence-Data-END## PREDICTED REFSEQ: This record has not been reviewed and the function is unknown. The reference sequence was derived from BX088533.9. On May 24, 2007 this sequence version replaced XP_683723.2., [RefSeq]",
    "predicted_glycosites": 1,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 1,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 1,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 2,
    "glyco_site_count": 1,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0003730 mRNA 3'-UTR binding",
    "go_cellular_component": "GO:0005634 nucleus;GO:0005737 cytoplasm;GO:0005829 cytosol",
    "go_biological_process": "GO:0070934 CRD-mediated mRNA stabilization;GO:0007399 nervous system development",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0R4IVY2-1",
    "record_type": "protein",
    "filter_code": "0000000.0000111.100000.0000000000000001.00010.001"
}